title: Efficacy of papaverine addition for treatment-refractory major depression.
authors.forename: R T
authors.initials: RT
authors.lastname: Malison
authors.forename: L H
authors.initials: LH
authors.lastname: Price
authors.forename: E J
authors.initials: EJ
authors.lastname: Nestler
authors.forename: G R
authors.initials: GR
authors.lastname: Heninger
authors.forename: R S
authors.initials: RS
authors.lastname: Duman
mesh_terms: D002065:Buspirone / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008875:Middle Aged; D010208:Papaverine / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
chemical_list: D002065:Buspirone; D003511:Cyclohexanols; D008094:Lithium; D010208:Papaverine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride